Skip to content

PBYI

Puma Biotechnology, Inc.

NASDAQ · USHealthcareBiotechnology
$8.30-2.70%

Price as of Jul 20, 2026

PBYI capital

Puma Biotechnology, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.12x
Net debt / equity
-0.16x
Debt / assets
0.08x
Debt / EBITDA
0.36x
Net debt / EBITDA
-0.45x

Liquidity & coverage

Current ratio
2.38x
Quick ratio
2.24x
Cash ratio
1.70x
Interest coverage
5.70x
EBITDA / interest
8.68x
Working capital
$82.5M

Cash & dividend

FCF / debt
3.36x
Cash flow / debt
3.36x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.